News & Filings
MANKIND \u2014 Recent Activity
9 items in the last 14 days
Please find attached intimation of payment of interest and redemption amount to the NCD holders of the Company.
Click to open →
Board of Directors of the Company in its meeting held on April 13, 2026 i.e. today, approved the closure/winding up of Mankind Pharma Lanka (Private) Limited, a WOS incorporated in Sri Lanka.
Click to open →
Please find attached outcome of board meeting held on April 13, 2026
Click to open →
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires this week,
Click to open →
India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs
Novo Nordisk's semaglutide patent expires March 20 as Indian drugmakers prepare lower-cost versions and hospitals expand obesity clinics.
Click to open →
Mankind Pharma Ltd (NSE:MANKIND) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Mankind Pharma Ltd (NSE:MANKIND) reports an 11.5% revenue increase in Q3 FY26, driven by robust domestic and export performance, despite challenges in margins and specific segments.
Click to open →
Indian drugmaker Mankind Pharma posts higher quarterly profit on strong chronic drugs demand
Feb 3 (Reuters) - Indian drugmaker Mankind Pharma reported a higher third-quarter profit on Tuesday, driven by strong domestic demand for its drugs used for treating long-term illnesses.
Click to open →
India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe
(Reuters) -India's Glenmark Pharmaceuticals reported a 72% jump in second-quarter adjusted profit on Friday, on recovery in key North American and European markets.
Click to open →
Mankind Pharma posts fourth straight quarterly profit fall on sales hit from tax cuts
(Reuters) -India's Mankind Pharma reported a fourth straight quarter of profit fall on Thursday, as the government's sweeping cuts on its goods and services taxes caused supply chain disruptions,
Click to open →
Get alerts for important filings
Add MANKIND to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.